$MSLP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MusclePharm Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in MusclePharm Corp. Get notifications about new insider transactions in MusclePharm Corp for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 02 2019 | MSLP | MusclePharm Corp | White Winston Select Asset Fun ... | 10% Owner | Buy | P | 0.00 | 626,826 | 0 | 3,658,180 | 3 M to 3.7 M (+20.68 %) |
Oct 01 2019 | MSLP | MusclePharm Corp | White Winston Select Asset Fun ... | 10% Owner | Buy | P | 0.00 | 103,677 | 0 | 3,031,354 | 2.9 M to 3 M (+3.54 %) |
Sep 20 2019 | MSLP | MusclePharm Corp | Drexler Ryan Charles | CEO | Buy | C | 1.11 | 16,216,216 | 18,000,000 | 16,879,253 | 663 K to 16.9 M (+2,445.75 %) |
Sep 20 2019 | MSLP | MusclePharm Corp | Drexler Ryan Charles | CEO | Buy | J | 0.65 | 81,113 | 52,723 | 663,037 | 581.9 K to 663 K (+13.94 %) |
Sep 16 2019 | MSLP | MusclePharm Corp | BUSH WILLIAM JOHN | Grant | A | 0.00 | 238,095 | 0 | 492,181 | 254.1 K to 492.2 K (+93.71 %) | |
Sep 16 2019 | MSLP | MusclePharm Corp | Desmond John J | Grant | A | 0.00 | 357,143 | 0 | 587,357 | 230.2 K to 587.4 K (+155.14 %) | |
Aug 21 2019 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.40 | 10,100 | 4,040 | 1,196,123 | 1.2 M to 1.2 M (+0.85 %) |
Aug 21 2019 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.40 | 4,900 | 1,960 | 1,186,023 | 1.2 M to 1.2 M (+0.41 %) |
Aug 16 2019 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.40 | 4,600 | 1,840 | 1,181,123 | 1.2 M to 1.2 M (+0.39 %) |
Aug 16 2019 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.41 | 5,400 | 2,198 | 1,176,523 | 1.2 M to 1.2 M (+0.46 %) |
Aug 16 2019 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.40 | 4,600 | 1,840 | 1,181,123 | 1.2 M to 1.2 M (+0.39 %) |
Aug 16 2019 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.41 | 5,400 | 2,198 | 1,176,523 | 1.2 M to 1.2 M (+0.46 %) |
Apr 10 2019 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.60 | 6,530 | 3,918 | 1,168,563 | 1.2 M to 1.2 M (+0.56 %) |
Apr 10 2019 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.60 | 6,176 | 3,706 | 732,742 | 726.6 K to 732.7 K (+0.85 %) |
Mar 21 2019 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.63 | 2,617 | 1,649 | 1,162,033 | 1.2 M to 1.2 M (+0.23 %) |
Mar 21 2019 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.63 | 2,469 | 1,555 | 726,566 | 724.1 K to 726.6 K (+0.34 %) |
Mar 08 2019 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.63 | 6,112 | 3,851 | 1,159,416 | 1.2 M to 1.2 M (+0.53 %) |
Mar 08 2019 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.63 | 6,096 | 3,840 | 724,097 | 718 K to 724.1 K (+0.85 %) |
Feb 08 2019 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.40 | 25,740 | 10,296 | 1,153,304 | 1.1 M to 1.2 M (+2.28 %) |
Feb 08 2019 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.40 | 13,860 | 5,544 | 718,001 | 704.1 K to 718 K (+1.97 %) |
Feb 08 2019 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.40 | 39,260 | 15,704 | 1,127,564 | 1.1 M to 1.1 M (+3.61 %) |
Feb 08 2019 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.40 | 21,140 | 8,456 | 704,141 | 683 K to 704.1 K (+3.10 %) |
Jan 03 2019 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.57 | 27,925 | 15,954 | 1,088,304 | 1.1 M to 1.1 M (+2.63 %) |
Dec 31 2018 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.57 | 2,075 | 1,173 | 1,060,379 | 1.1 M to 1.1 M (+0.20 %) |
Dec 13 2018 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.90 | 20,000 | 18,000 | 1,058,304 | 1 M to 1.1 M (+1.93 %) |
Dec 13 2018 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.90 | 40,000 | 35,800 | 1,038,304 | 998.3 K to 1 M (+4.01 %) |
Dec 04 2018 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.90 | 7,000 | 6,270 | 998,304 | 991.3 K to 998.3 K (+0.71 %) |
Nov 28 2018 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.90 | 1,000 | 900 | 991,304 | 990.3 K to 991.3 K (+0.10 %) |
Nov 28 2018 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.90 | 1,400 | 1,260 | 990,304 | 988.9 K to 990.3 K (+0.14 %) |
Nov 28 2018 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.90 | 600 | 540 | 683,001 | 682.4 K to 683 K (+0.09 %) |
Oct 18 2018 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 1.00 | 8,059 | 8,059 | 988,904 | 980.8 K to 988.9 K (+0.82 %) |
Oct 18 2018 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 1.00 | 6,941 | 6,941 | 682,401 | 675.5 K to 682.4 K (+1.03 %) |
Aug 24 2018 | MSLP | MusclePharm Corp | BUSH WILLIAM JOHN | Grant | A | 0.00 | 100,000 | 0 | 254,086 | 154.1 K to 254.1 K (+64.90 %) | |
Aug 23 2018 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 1.00 | 13,000 | 13,000 | 980,845 | 967.8 K to 980.8 K (+1.34 %) |
Aug 16 2018 | MSLP | MusclePharm Corp | Desmond John J | Grant | A | 0.00 | 150,000 | 0 | 230,214 | 80.2 K to 230.2 K (+187.00 %) | |
Jul 12 2018 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.99 | 14,421 | 14,330 | 917,845 | 903.4 K to 917.8 K (+1.60 %) |
Jul 12 2018 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.99 | 12,579 | 12,500 | 725,460 | 712.9 K to 725.5 K (+1.76 %) |
Jul 12 2018 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.98 | 34,021 | 33,211 | 903,424 | 869.4 K to 903.4 K (+3.91 %) |
Jul 12 2018 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 0.98 | 33,454 | 32,658 | 712,881 | 679.4 K to 712.9 K (+4.92 %) |
Jun 29 2018 | MSLP | MusclePharm Corp | Amerop Holdings, Inc. | 10% Owner | Sell | S | 1.00 | 747,942 | 747,942 | 0 | 747.9 K to 0 (-100.00 %) |
Mar 29 2018 | MSLP | MusclePharm Corp | Desmond John J | Grant | A | 0.00 | 80,214 | 0 | 80,214 | 0 to 80.2 K | |
Dec 29 2017 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Sell | S | 1.00 | 120,000 | 120,000 | 762,068 | 882.1 K to 762.1 K (-13.60 %) |
Dec 29 2017 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Sell | S | 1.00 | 180,000 | 180,000 | 574,237 | 754.2 K to 574.2 K (-23.87 %) |
Sep 22 2017 | MSLP | MusclePharm Corp | BUSH WILLIAM JOHN | Director | Grant | A | 0.00 | 53,476 | 0 | 154,086 | 100.6 K to 154.1 K (+53.15 %) |
Sep 22 2017 | MSLP | MusclePharm Corp | BUSH WILLIAM JOHN | Director | Grant | A | 0.00 | 10,081 | 0 | 100,610 | 90.5 K to 100.6 K (+11.14 %) |
Aug 22 2017 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 1.41 | 2,524 | 3,559 | 882,068 | 879.5 K to 882.1 K (+0.29 %) |
Aug 22 2017 | MSLP | MusclePharm Corp | WYNNEFIELD PARTNERS SMALL CAP ... | 10% Owner | Buy | P | 1.41 | 2,476 | 3,491 | 754,237 | 751.8 K to 754.2 K (+0.33 %) |
May 15 2017 | MSLP | MusclePharm Corp | Amerop Holdings, Inc. | 10% Owner | Buy | P | 2.00 | 75,000 | 150,000 | 2,211,781 | 2.1 M to 2.2 M (+3.51 %) |
Apr 11 2017 | MSLP | MusclePharm Corp | Amerop Holdings, Inc. | 10% Owner | Buy | P | 2.15 | 14,000 | 30,099 | 2,136,781 | 2.1 M to 2.1 M (+0.66 %) |
Apr 11 2017 | MSLP | MusclePharm Corp | Amerop Holdings, Inc. | 10% Owner | Buy | P | 2.17 | 2,300 | 4,991 | 2,122,781 | 2.1 M to 2.1 M (+0.11 %) |
Apr 11 2017 | MSLP | MusclePharm Corp | Amerop Holdings, Inc. | 10% Owner | Buy | P | 2.17 | 500 | 1,085 | 2,120,481 | 2.1 M to 2.1 M (+0.02 %) |
Apr 11 2017 | MSLP | MusclePharm Corp | Amerop Holdings, Inc. | 10% Owner | Buy | P | 2.17 | 300 | 651 | 2,119,981 | 2.1 M to 2.1 M (+0.01 %) |
Apr 11 2017 | MSLP | MusclePharm Corp | Amerop Holdings, Inc. | 10% Owner | Buy | P | 2.17 | 2,200 | 4,774 | 2,119,681 | 2.1 M to 2.1 M (+0.10 %) |
Apr 06 2017 | MSLP | MusclePharm Corp | Amerop Holdings, Inc. | 10% Owner | Buy | P | 2.15 | 41,900 | 90,068 | 2,117,481 | 2.1 M to 2.1 M (+2.02 %) |
Apr 06 2017 | MSLP | MusclePharm Corp | Amerop Holdings, Inc. | 10% Owner | Buy | P | 2.15 | 5,000 | 10,725 | 2,075,581 | 2.1 M to 2.1 M (+0.24 %) |
Apr 06 2017 | MSLP | MusclePharm Corp | Amerop Holdings, Inc. | 10% Owner | Buy | P | 2.15 | 152 | 327 | 2,070,581 | 2.1 M to 2.1 M (+0.01 %) |
Apr 06 2017 | MSLP | MusclePharm Corp | Amerop Holdings, Inc. | 10% Owner | Buy | P | 2.14 | 2,500 | 5,350 | 2,070,429 | 2.1 M to 2.1 M (+0.12 %) |
Apr 06 2017 | MSLP | MusclePharm Corp | Amerop Holdings, Inc. | 10% Owner | Buy | P | 2.13 | 762 | 1,623 | 2,067,929 | 2.1 M to 2.1 M (+0.04 %) |
Apr 06 2017 | MSLP | MusclePharm Corp | Amerop Holdings, Inc. | 10% Owner | Buy | P | 2.12 | 762 | 1,612 | 2,067,167 | 2.1 M to 2.1 M (+0.04 %) |
Apr 06 2017 | MSLP | MusclePharm Corp | Amerop Holdings, Inc. | 10% Owner | Buy | P | 2.12 | 762 | 1,612 | 2,066,405 | 2.1 M to 2.1 M (+0.04 %) |
Apr 06 2017 | MSLP | MusclePharm Corp | Amerop Holdings, Inc. | 10% Owner | Buy | P | 2.12 | 762 | 1,612 | 2,065,643 | 2.1 M to 2.1 M (+0.04 %) |
Apr 06 2017 | MSLP | MusclePharm Corp | Amerop Holdings, Inc. | 10% Owner | Buy | P | 2.12 | 34,800 | 73,776 | 2,064,881 | 2 M to 2.1 M (+1.71 %) |
Apr 06 2017 | MSLP | MusclePharm Corp | Amerop Holdings, Inc. | 10% Owner | Buy | P | 2.11 | 100 | 211 | 2,030,081 | 2 M to 2 M (0.00 %) |
Apr 06 2017 | MSLP | MusclePharm Corp | Amerop Holdings, Inc. | 10% Owner | Buy | P | 2.11 | 100 | 211 | 2,029,981 | 2 M to 2 M (0.00 %) |
Dec 12 2016 | MSLP | MusclePharm Corp | Drexler Ryan Charles | See Remarks. | Grant | A | 0.00 | 550,000 | 0 | 581,924 | 31.9 K to 581.9 K (+1,722.84 %) |
Dec 08 2016 | MSLP | MusclePharm Corp | Lynch Peter Christopher | Chief Financial Off ... | Option Exercise | A | 2.39 | 139,277 | 332,872 | 139,277 | |
Nov 14 2016 | MSLP | MusclePharm Corp | Drexler Ryan Charles | Executive Chairman | Option Exercise | J | 1.83 | 6,010,929 | 11,000,000 | 8,619,624 | |
Sep 02 2016 | MSLP | MusclePharm Corp | Jenkins Stacey Y | Director | Grant | A | 0.00 | 64,338 | 0 | 90,529 | 26.2 K to 90.5 K (+245.65 %) |
Sep 02 2016 | MSLP | MusclePharm Corp | Doron Michael J | Director | Grant | A | 0.00 | 64,338 | 0 | 150,314 | 86 K to 150.3 K (+74.83 %) |
Sep 02 2016 | MSLP | MusclePharm Corp | BUSH WILLIAM JOHN | Director | Grant | A | 0.00 | 64,338 | 0 | 90,529 | 26.2 K to 90.5 K (+245.65 %) |
Sep 02 2016 | MSLP | MusclePharm Corp | Jenkins Stacey Y | Director | Grant | A | 0.00 | 6,779 | 0 | 26,191 | 19.4 K to 26.2 K (+34.92 %) |
Sep 02 2016 | MSLP | MusclePharm Corp | Doron Michael J | Director | Grant | A | 0.00 | 6,779 | 0 | 85,976 | 79.2 K to 86 K (+8.56 %) |
Sep 02 2016 | MSLP | MusclePharm Corp | BUSH WILLIAM JOHN | Director | Grant | A | 0.00 | 6,779 | 0 | 26,191 | 19.4 K to 26.2 K (+34.92 %) |
Feb 23 2016 | MSLP | MusclePharm Corp | Drexler Ryan Charles | Executive Chairman | Option Exercise | A | 1.89 | 137,362 | 259,614 | 137,362 | |
Feb 23 2016 | MSLP | MusclePharm Corp | Doron Michael J | Director | Option Exercise | A | 1.89 | 54,945 | 103,846 | 54,945 | |
Nov 12 2015 | MSLP | MusclePharm Corp | Doron Michael J | Director | Grant | A | 0.00 | 7,010 | 0 | 70,148 | 63.1 K to 70.1 K (+11.10 %) |
Nov 12 2015 | MSLP | MusclePharm Corp | Doron Michael J | Director | Grant | A | 0.00 | 3,353 | 0 | 63,138 | 59.8 K to 63.1 K (+5.61 %) |
Nov 12 2015 | MSLP | MusclePharm Corp | Jenkins Stacey Y | Director | Grant | A | 0.00 | 7,010 | 0 | 10,363 | 3.4 K to 10.4 K (+209.07 %) |
Nov 12 2015 | MSLP | MusclePharm Corp | Jenkins Stacey Y | Director | Grant | A | 0.00 | 3,353 | 0 | 3,353 | 0 to 3.4 K |
Feb 01 2016 | MSLP | MusclePharm Corp | Doron Michael J | Director | Grant | A | 0.00 | 9,049 | 0 | 79,197 | 70.1 K to 79.2 K (+12.90 %) |
Feb 01 2016 | MSLP | MusclePharm Corp | Estalella Richard | Director | Grant | A | 0.00 | 9,049 | 0 | 379,049 | 370 K to 379 K (+2.45 %) |
Feb 01 2016 | MSLP | MusclePharm Corp | Thompson Noel | Director | Grant | A | 0.00 | 9,049 | 0 | 19,412 | 10.4 K to 19.4 K (+87.32 %) |
Feb 01 2016 | MSLP | MusclePharm Corp | Jenkins Stacey Y | Director | Grant | A | 0.00 | 9,049 | 0 | 19,412 | 10.4 K to 19.4 K (+87.32 %) |
Feb 01 2016 | MSLP | MusclePharm Corp | BUSH WILLIAM JOHN | Director | Grant | A | 0.00 | 9,049 | 0 | 19,412 | 10.4 K to 19.4 K (+87.32 %) |
Nov 12 2015 | MSLP | MusclePharm Corp | Thompson Noel | Director | Grant | A | 0.00 | 7,010 | 0 | 10,363 | 3.4 K to 10.4 K (+209.07 %) |
Nov 12 2015 | MSLP | MusclePharm Corp | Thompson Noel | Director | Grant | A | 0.00 | 3,353 | 0 | 3,353 | 0 to 3.4 K |
Nov 12 2015 | MSLP | MusclePharm Corp | Drexler Ryan Charles | Director | Buy | J | 0.00 | 28,571 | 0 | 31,924 | 3.4 K to 31.9 K (+852.10 %) |
Nov 12 2015 | MSLP | MusclePharm Corp | Drexler Ryan Charles | Director | Grant | A | 0.00 | 3,353 | 0 | 3,353 | 0 to 3.4 K |
Nov 12 2015 | MSLP | MusclePharm Corp | BUSH WILLIAM JOHN | Director | Grant | A | 0.00 | 7,010 | 0 | 10,363 | 3.4 K to 10.4 K (+209.07 %) |
Nov 12 2015 | MSLP | MusclePharm Corp | BUSH WILLIAM JOHN | Director | Grant | A | 0.00 | 3,353 | 0 | 3,353 | 0 to 3.4 K |
Oct 14 2015 | MSLP | MusclePharm Corp | Gregory Cory J | Executive Vice Pres ... | Sell | J | 0.00 | 80,000 | 0 | 268,330 | 348.3 K to 268.3 K (-22.97 %) |
Oct 07 2015 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Sell | J | 0.00 | 90,418 | 0 | 885,025 | 975.4 K to 885 K (-9.27 %) |
Jul 06 2015 | MSLP | MusclePharm Corp | Gregory Cory J | Executive Vice Pres ... | Sell | J | 0.00 | 63,325 | 0 | 348,330 | 411.7 K to 348.3 K (-15.38 %) |
Jul 01 2015 | MSLP | MusclePharm Corp | Doron Michael J | Director | Grant | A | 0.00 | 4,446 | 0 | 59,785 | 55.3 K to 59.8 K (+8.03 %) |
Jul 01 2015 | MSLP | MusclePharm Corp | Doron Michael J | Director | Grant | A | 0.00 | 2,167 | 0 | 55,339 | 53.2 K to 55.3 K (+4.08 %) |
May 08 2015 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Sell | J | 0.00 | 100,000 | 0 | 975,443 | 1.1 M to 975.4 K (-9.30 %) |
May 05 2015 | MSLP | MusclePharm Corp | Price John C | Chief Financial Off ... | Buy | J | 0.00 | 50,000 | 0 | 100,000 | 50 K to 100 K (+100.00 %) |
Nov 25 2014 | MSLP | MusclePharm Corp | Lupo Andrew J | Director | Buy | P | 10.73 | 12,710 | 136,378 | 19,677 | 7 K to 19.7 K (+182.43 %) |
Nov 25 2014 | MSLP | MusclePharm Corp | Lupo Andrew J | Director | Buy | P | 10.20 | 3,300 | 33,660 | 6,967 | 3.7 K to 7 K (+89.99 %) |
Nov 24 2014 | MSLP | MusclePharm Corp | Lupo Andrew J | Director | Buy | P | 10.11 | 153 | 1,547 | 3,667 | 3.5 K to 3.7 K (+4.35 %) |
Nov 24 2014 | MSLP | MusclePharm Corp | Lupo Andrew J | Director | Buy | P | 10.10 | 47 | 475 | 3,514 | 3.5 K to 3.5 K (+1.36 %) |
Nov 24 2014 | MSLP | MusclePharm Corp | Lupo Andrew J | Director | Buy | P | 10.10 | 900 | 9,090 | 3,467 | 2.6 K to 3.5 K (+35.06 %) |
Nov 24 2014 | MSLP | MusclePharm Corp | Lupo Andrew J | Director | Buy | P | 10.10 | 1,100 | 11,110 | 2,567 | 1.5 K to 2.6 K (+74.98 %) |
Nov 20 2014 | MSLP | MusclePharm Corp | Greenwell James J | Chief Operating Off ... | Buy | P | 9.90 | 1,000 | 9,900 | 162,172 | 161.2 K to 162.2 K (+0.62 %) |
Nov 20 2014 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 10.15 | 100 | 1,015 | 1,075,443 | 1.1 M to 1.1 M (+0.01 %) |
Nov 20 2014 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 10.14 | 6,700 | 67,938 | 1,075,343 | 1.1 M to 1.1 M (+0.63 %) |
Nov 20 2014 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 10.05 | 100 | 1,005 | 1,068,643 | 1.1 M to 1.1 M (+0.01 %) |
Nov 20 2014 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 10.02 | 100 | 1,002 | 1,068,543 | 1.1 M to 1.1 M (+0.01 %) |
Nov 20 2014 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 9.99 | 1,700 | 16,983 | 1,068,443 | 1.1 M to 1.1 M (+0.16 %) |
Nov 20 2014 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 9.98 | 100 | 998 | 1,066,743 | 1.1 M to 1.1 M (+0.01 %) |
Nov 20 2014 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 9.95 | 1,100 | 10,945 | 1,066,643 | 1.1 M to 1.1 M (+0.10 %) |
Nov 18 2014 | MSLP | MusclePharm Corp | Lupo Andrew J | Director | Grant | A | 0.00 | 1,467 | 0 | 1,467 | 0 to 1.5 K |
Nov 18 2014 | MSLP | MusclePharm Corp | MACOSKO GREGORY | Director | Grant | A | 0.00 | 3,281 | 0 | 3,281 | 0 to 3.3 K |
Nov 18 2014 | MSLP | MusclePharm Corp | PROSSER DONALD W | Chief Financial Off ... | Grant | A | 0.00 | 100,000 | 0 | 152,172 | 52.2 K to 152.2 K (+191.67 %) |
Nov 18 2014 | MSLP | MusclePharm Corp | Greenwell James J | Chief Operating Off ... | Grant | A | 0.00 | 100,000 | 0 | 161,172 | 61.2 K to 161.2 K (+163.47 %) |
Nov 18 2014 | MSLP | MusclePharm Corp | Gregory Cory J | Executive Vice Pres ... | Grant | A | 0.00 | 100,000 | 0 | 411,655 | 311.7 K to 411.7 K (+32.09 %) |
Nov 18 2014 | MSLP | MusclePharm Corp | Estalella Richard | President | Grant | A | 0.00 | 250,000 | 0 | 370,000 | 120 K to 370 K (+208.33 %) |
Nov 17 2014 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Grant | A | 13.00 | 500,000 | 6,500,000 | 1,065,543 | 565.5 K to 1.1 M (+88.41 %) |
Sep 22 2014 | MSLP | MusclePharm Corp | MACOSKO GREGORY | Director | Buy | P | 13.21 | 1,000 | 13,210 | 2,000 | 1,000 to 2 K (+100.00 %) |
Sep 05 2014 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 13.60 | 500 | 6,800 | 564,080 | 563.6 K to 564.1 K (+0.09 %) |
Aug 22 2014 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 12.15 | 214 | 2,600 | 563,580 | 563.4 K to 563.6 K (+0.04 %) |
Aug 22 2014 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 12.15 | 1,000 | 12,150 | 563,366 | 562.4 K to 563.4 K (+0.18 %) |
Aug 22 2014 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 12.15 | 3,944 | 47,920 | 562,366 | 558.4 K to 562.4 K (+0.71 %) |
Aug 22 2014 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 12.15 | 200 | 2,430 | 558,422 | 558.2 K to 558.4 K (+0.04 %) |
Aug 15 2014 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 11.45 | 1,000 | 11,450 | 558,222 | 557.2 K to 558.2 K (+0.18 %) |
Aug 15 2014 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 11.50 | 1,000 | 11,500 | 557,222 | 556.2 K to 557.2 K (+0.18 %) |
Aug 15 2014 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 11.50 | 500 | 5,750 | 556,222 | 555.7 K to 556.2 K (+0.09 %) |
Aug 12 2014 | MSLP | MusclePharm Corp | Greenwell James J | Chief Operating Off ... | Buy | P | 11.00 | 1,000 | 11,000 | 61,172 | 60.2 K to 61.2 K (+1.66 %) |
Aug 08 2014 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 11.10 | 2,000 | 22,200 | 555,722 | 553.7 K to 555.7 K (+0.36 %) |
Aug 08 2014 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 11.06 | 1,100 | 12,166 | 553,722 | 552.6 K to 553.7 K (+0.20 %) |
Aug 08 2014 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 11.15 | 2,500 | 27,875 | 552,622 | 550.1 K to 552.6 K (+0.45 %) |
Aug 08 2014 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 11.50 | 3,511 | 40,377 | 550,122 | 546.6 K to 550.1 K (+0.64 %) |
Aug 08 2014 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 11.20 | 189 | 2,117 | 546,611 | 546.4 K to 546.6 K (+0.03 %) |
Aug 08 2014 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 11.30 | 4,200 | 47,460 | 546,422 | 542.2 K to 546.4 K (+0.77 %) |
Aug 08 2014 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 11.25 | 1,500 | 16,875 | 542,222 | 540.7 K to 542.2 K (+0.28 %) |
May 14 2014 | MSLP | MusclePharm Corp | Doron Michael J | Director | Buy | P | 10.14 | 1,000 | 10,140 | 53,172 | 52.2 K to 53.2 K (+1.92 %) |
May 14 2014 | MSLP | MusclePharm Corp | ROLLOCK SYDNEY R | Chief Marketing & S ... | Grant | A | 0.00 | 75,000 | 0 | 89,505 | 14.5 K to 89.5 K (+517.06 %) |
May 08 2014 | MSLP | MusclePharm Corp | Estalella Richard | President | Buy | P | 9.80 | 10,000 | 98,000 | 120,000 | 110 K to 120 K (+9.09 %) |
Apr 01 2014 | MSLP | MusclePharm Corp | PROSSER DONALD W | Director | Grant | A | 0.00 | 12,214 | 0 | 52,172 | 40 K to 52.2 K (+30.57 %) |
Apr 01 2014 | MSLP | MusclePharm Corp | Doron Michael J | Director | Grant | A | 0.00 | 12,214 | 0 | 52,172 | 40 K to 52.2 K (+30.57 %) |
Apr 01 2014 | MSLP | MusclePharm Corp | Greenwell James J | Director | Grant | A | 0.00 | 12,214 | 0 | 60,172 | 48 K to 60.2 K (+25.47 %) |
Apr 01 2014 | MSLP | MusclePharm Corp | mcclory daniel joseph | Director | Grant | A | 0.00 | 12,214 | 0 | 17,290 | 5.1 K to 17.3 K (+240.62 %) |
Feb 13 2014 | MSLP | MusclePharm Corp | BLUHER JOHN H | Sell | S | 9.10 | 3,000 | 27,300 | 190,118 | 193.1 K to 190.1 K (-1.55 %) | |
Jan 03 2014 | MSLP | MusclePharm Corp | Doron Michael J | Director | Grant | A | 0.00 | 5,096 | 0 | 39,958 | 34.9 K to 40 K (+14.62 %) |
Jan 03 2014 | MSLP | MusclePharm Corp | Greenwell James J | Director | Grant | A | 0.00 | 5,096 | 0 | 47,958 | 42.9 K to 48 K (+11.89 %) |
Jan 03 2014 | MSLP | MusclePharm Corp | mcclory daniel joseph | Director | Grant | A | 0.00 | 1,000 | 0 | 5,076 | 4.1 K to 5.1 K (+24.53 %) |
Jan 03 2014 | MSLP | MusclePharm Corp | mcclory daniel joseph | Director | Grant | A | 0.00 | 4,076 | 0 | 4,076 | 0 to 4.1 K |
Jan 03 2014 | MSLP | MusclePharm Corp | PROSSER DONALD W | Director | Grant | A | 0.00 | 5,096 | 0 | 39,958 | 34.9 K to 40 K (+14.62 %) |
Dec 06 2013 | MSLP | MusclePharm Corp | Greenwell James J | Director | Grant | A | 7.75 | 1,000 | 7,750 | 42,862 | 41.9 K to 42.9 K (+2.39 %) |
Dec 06 2013 | MSLP | MusclePharm Corp | Greenwell James J | Director | Grant | A | 8.00 | 2,000 | 16,000 | 41,862 | 39.9 K to 41.9 K (+5.02 %) |